BioDlink International names Fu Shan executive director amid leadership changes

BioDlink International Company Limited (BioDlink) announced the re-designation of Fu Shan from non-executive director to executive director, effective October 11, 2025. In this new role, Fu will lead and oversee the Group's management and development. He will also maintain his positions as chairperson of the Board, the Nomination Committee, and the Strategy and ESG Committee. Fu will serve a fixed term until March 11, 2028, and has voluntarily agreed to a nominal annual director's fee of HK$1 for his executive director services.

The company also reported the resignations of Dr. Liu Jun and Ms. Yeh-Huang Chun-Ying, both effective October 11, 2025, due to personal reasons. Dr. Liu will step down as executive director, chief executive officer, chief scientific officer, and a member of the Strategy and ESG Committee. Ms. Yeh-Huang will resign as non-executive director, vice chairperson of the Board, and a member of the Strategy and ESG Committee. Both will also retire from all directorships and executive positions within BioDlink's subsidiaries but will continue as strategic consultants for the Group.

Furthermore, Fu Shan has been appointed as an authorised representative of the company, replacing Dr. Liu Jun, effective October 11, 2025. As of the announcement date, the executive director is Fu Shan; the non-executive director is Dr. Liu Weidong; and the independent non-executive directors are Ms. Sun Hui, Mr. Zhang Qing, and Dr. Gu Xuelin.